Avalyn Pharma Inc (AVLN)

Sep 26, 2026

LB Pharmaceuticals Inc (LBRX) Stock Price & News - Syfe

Sep 26, 2026

Sep 25, 2026

Neurogene Inc. (NGNE) Stock Price & News - Syfe

Sep 25, 2026

Sep 21, 2026

Avalyn Publishes Phase 1 Data Highlighting AP02’s Lung-Targeted Delivery and Encouraging Safety Profile - Stock Titan

Sep 21, 2026

Sep 16, 2026

Avalyn Pharma (AVLN) adds ex-FDA leader to its board - Stock Titan

Sep 16, 2026

Sep 12, 2026

Avalyn Pharma (NASDAQ:AVLN) Rating Increased to Hold at Wall Street Zen - MarketBeat

Sep 12, 2026

Sep 10, 2026

Bank of New York Mellon Corp Acquires New Shares in Avalyn Pharma Inc. $AVLN - MarketBeat

Sep 10, 2026

Sep 09, 2026

Nuvectis Pharma, Inc. (NVCT) Stock Price & News - Syfe

Sep 09, 2026

Sep 09, 2026

AQST Stock Price, Quote & News - Syfe

Sep 09, 2026

Sep 08, 2026

Avalyn Pharma presents AP01 lung distribution modeling data By Investing.com - Investing.com Canada

Sep 08, 2026

Sep 08, 2026

Avalyn Pharma presents AP01 lung distribution modeling data By Investing.com - Investing.com Australia

Sep 08, 2026

Sep 08, 2026

Avalyn Pharma presents AP01 lung distribution modeling data By Investing.com - Investing.com India

Sep 08, 2026

Sep 08, 2026

Avalyn Pharma presents AP01 lung distribution modeling data - investing.com

Sep 08, 2026

Sep 08, 2026

Avalyn Pharma presents AP01 lung distribution modeling data By Investing.com - Investing.com UK

Sep 08, 2026

Sep 08, 2026

People with lung scarring are willing to travel for trials, Avalyn survey finds - Stock Titan

Sep 08, 2026

Sep 08, 2026

Morgan Stanley's New York healthcare event will include Avalyn Sept. 14 - Stock Titan

Sep 08, 2026

Sep 06, 2026

Avalyn Pharma Inc. (NASDAQ:AVLN) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat

Sep 06, 2026

Sep 03, 2026

AVLN Options Overview History for Avalyn Pharma Stock - Barchart.com

Sep 03, 2026

Sep 03, 2026

Braidwell LP Invests $26.38 Million in Avalyn Pharma Inc. $AVLN - MarketBeat

Sep 03, 2026

Sep 01, 2026

Montanova Capital LLC Takes Position in Avalyn Pharma Inc. $AVLN - MarketBeat

Sep 01, 2026

Aug 24, 2026

Avalyn Announces Multiple Presentations at the European Respiratory Society International Congress 2026 - Barchart.com

Aug 24, 2026

Aug 24, 2026

Avalyn will present a model of how an inhaled treatment may spread through the lungs - Stock Titan

Aug 24, 2026

Aug 22, 2026

AVLN Options Volatility — NASDAQ:AVLN - TradingView

Aug 22, 2026

Aug 22, 2026

AVLN Options Chain — NASDAQ:AVLN - TradingView

Aug 22, 2026

Aug 19, 2026

Avalyn Pharma (NASDAQ:AVLN) Sets New 1-Year HighHere's Why - MarketBeat

Aug 19, 2026

Aug 15, 2026

Avalyn Pharma (NASDAQ:AVLN) Cut to Sell at Wall Street Zen - MarketBeat

Aug 15, 2026

Aug 14, 2026

Novo Holdings A/S (AVLN) discloses 8.8% beneficial stake in Avalyn Pharma - Stock Titan

Aug 14, 2026

Aug 13, 2026

Jefferies Maintains Avalyn Pharma(AVLN.US) With Buy Rating, Maintains Target Price $52 - Moomoo

Aug 13, 2026

Aug 13, 2026

Morgan Stanley Maintains Avalyn Pharma(AVLN.US) With Buy Rating, Raises Target Price to $57 - Moomoo

Aug 13, 2026

Aug 13, 2026

Avalyn Pharma (NASDAQ:AVLN) Hits New 52-Week High Following Better-Than-Expected Earnings - MarketBeat

Aug 13, 2026

Aug 13, 2026

AVLN SWOT Analysis: Financial Challenges and Growth Potential Re - GuruFocus

Aug 13, 2026

Aug 12, 2026

Avalyn Pharma Inc. Common Stock (NASDAQ: AVLN) Stock Price, News & Analysis - Kalkine

Aug 12, 2026

Aug 12, 2026

Avalyn Pharma Inc. Common Stock (NASDAQ: AVLN) Stock Price, News & Analysis - kalkine.ca

Aug 12, 2026

Aug 12, 2026

Avalyn Pharma Q2 Results: EPS misses estimate by 22.64% - scanx.trade

Aug 12, 2026

Aug 12, 2026

Avalyn Pharma (NASDAQ:AVLN) Trading Up 8.2% Following Better-Than-Expected Earnings - MarketBeat

Aug 12, 2026

Aug 12, 2026

Form 8K Avalyn Pharma Inc. For: 12 August By Investing.com - Investing.com Nigeria

Aug 12, 2026

Aug 12, 2026

Avalyn Pharma Inc. Q2 2026: Net loss $(28.9M), EPS $(0.98) — 10-Q Summary - TradingView

Aug 12, 2026

Aug 12, 2026

Avalyn Pharma's Q2 Net Loss Widens - Yahoo Finance

Aug 12, 2026

Aug 12, 2026

Avalyn: Q2 Earnings Snapshot - AOL.com

Aug 12, 2026

Aug 12, 2026

Avalyn: Q2 Earnings Snapshot - 10TV

Aug 12, 2026

Aug 12, 2026

AVLN: Completed Phase 2b trial enrollment and secured $413.5M cash runway into 2029 - TradingView

Aug 12, 2026

Aug 12, 2026

Form 8K Avalyn Pharma Inc. For: 12 August By Investing.com - Investing.com Canada

Aug 12, 2026

Aug 12, 2026

AVLN: Net loss widened on higher R&D spend; IPO proceeds extend cash runway into 2029 - TradingView

Aug 12, 2026

Aug 12, 2026

Avalyn Pharma reports Q2 2026 net loss $28.9M; cash $413.5M, runway into 2029 - TradingView

Aug 12, 2026

Aug 12, 2026

Form 8K Avalyn Pharma Inc. For: 12 August By Investing.com - Investing.com UK

Aug 12, 2026

Aug 12, 2026

Avalyn Reports Second Quarter 2026 Financial Results and Recent Business Highlights - marketscreener.com

Aug 12, 2026

Aug 12, 2026

Avalyn Reports Second Quarter 2026 Financial Results and Recent Business Highlights - GlobeNewswire

Aug 12, 2026

Aug 12, 2026

Avalyn Pharma Inc. (NASDAQ:AVLN) Given Average Recommendation of "Buy" by Analysts - MarketBeat

Aug 12, 2026

Aug 11, 2026

Avalyn Pharma (AVLN): Norwest Venture Partners discloses 5.1% ownership stake - Stock Titan

Aug 11, 2026

Aug 10, 2026

Biotech Stocks At 52-Week HighsHALO +20% On Q2 Results, FENC, AVLN, AMLX, CHE - RTTNews

Aug 10, 2026

Aug 07, 2026

Avalyn Pharma (NASDAQ:AVLN) Reaches New 52-Week HighTime to Buy? - MarketBeat

Aug 07, 2026